Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
European Urology Open Science
|
July 13, 2023
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
Stefanie Zschäbitz, Nadine Biernath, Thomas Hilser, et al.
European Urology Open Science
|
September 23, 2024
First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
Stefanie Fischer, Silke Gillessen, Odile Stalder, et al.
European Urology
|
March 16, 2024
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]
J Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19
Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
JNCI Cancer Spectrum
|
November 22, 2019
Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration Rate
Edward H Williams, Claire M Connell, James M J Weaver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial
Sacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.
Journal for Immunotherapy of Cancer
|
February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
World Journal of Urology
|
March 8, 2021
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
European Urology Open Science
|
July 13, 2023
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
Stefanie Zschäbitz, Nadine Biernath, Thomas Hilser, et al.
European Urology Open Science
|
September 23, 2024
First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
Stefanie Fischer, Silke Gillessen, Odile Stalder, et al.
European Urology
|
March 16, 2024
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31]
J Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19
Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
JNCI Cancer Spectrum
|
November 22, 2019
Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration Rate
Edward H Williams, Claire M Connell, James M J Weaver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial
Sacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.
Journal for Immunotherapy of Cancer
|
February 10, 2019
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou, Madeleine M Hipp, Ute Klinkhardt, et al.
World Journal of Urology
|
March 8, 2021
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Page
of 14